[go: up one dir, main page]

BR9908094A - Preparado combinado de estrogênio e antiestrogênio - Google Patents

Preparado combinado de estrogênio e antiestrogênio

Info

Publication number
BR9908094A
BR9908094A BR9908094-0A BR9908094A BR9908094A BR 9908094 A BR9908094 A BR 9908094A BR 9908094 A BR9908094 A BR 9908094A BR 9908094 A BR9908094 A BR 9908094A
Authority
BR
Brazil
Prior art keywords
estrogen
antiestrogen
preparation
estradiol
combined estrogen
Prior art date
Application number
BR9908094-0A
Other languages
English (en)
Inventor
Rudolf Knauthe
Christa Hegele-Hartung
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR9908094A publication Critical patent/BR9908094A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Patente de Invenção: <B>"PREPARADO COMBINADO DE ESTROGêNIO E ANTIESTROGêNIO"<D>. A invenção descreve um preparado combinado de um estrogênio e um antiestrogênio, caracterizado pelo fato de o estrogênio ser selecionado do grupo consistindo em 17-<225>-estradiol, 17-<244>-etinilestradiol, estriol, estrona, sulfato de estrona, sulfamatos de estrogênio, 17<244>-estradiol, mestranol, estilboestrol, e estrogênios naturalmente conjugados e pelo fato de o antiestrogênio ser um 7<244>-(<sym>-aminoalquil)estratrieno substituído da fórmula geral I: O preparado combinado de acordo com a invenção pode ser usado para terapia de substituição hormonal.
BR9908094-0A 1998-02-19 1999-02-18 Preparado combinado de estrogênio e antiestrogênio BR9908094A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19807791A DE19807791A1 (de) 1998-02-19 1998-02-19 Kombinationspräparat aus Östrogen und Antiöstrogen
PCT/EP1999/001023 WO1999042109A1 (de) 1998-02-19 1999-02-18 Kombinationspräparat aus östrogen und antiöstrogen

Publications (1)

Publication Number Publication Date
BR9908094A true BR9908094A (pt) 2000-10-31

Family

ID=7858786

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908094-0A BR9908094A (pt) 1998-02-19 1999-02-18 Preparado combinado de estrogênio e antiestrogênio

Country Status (12)

Country Link
US (1) US6677324B1 (pt)
EP (1) EP1054676A1 (pt)
JP (1) JP2002503695A (pt)
AR (1) AR017982A1 (pt)
AU (1) AU2834799A (pt)
BR (1) BR9908094A (pt)
CA (1) CA2321427A1 (pt)
DE (1) DE19807791A1 (pt)
IL (1) IL137491A0 (pt)
PE (1) PE20000261A1 (pt)
WO (1) WO1999042109A1 (pt)
ZA (1) ZA991370B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653298B2 (en) 2000-01-14 2003-11-25 Sterix Limited Composition
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
DE10039199A1 (de) * 2000-08-10 2002-02-21 Schering Ag Kombinationspräparate aus einem ERß selektiven Estrogen und einem SERM oder Antiestrogen
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
EP1749017A2 (en) * 2004-05-27 2007-02-07 MIGENIX Corp. Compounds and methods for cytoprotection
US7790910B2 (en) 2004-07-27 2010-09-07 Sicor Inc. Process for the preparation of 7α-alkylated 19-norsteroids
CN101014610B (zh) * 2004-09-08 2012-08-22 Msd欧斯股份有限公司 具有选择性雌激素活性的15β-取代的类固醇
AU2006317486B9 (en) 2005-11-22 2011-08-04 Sumitomo Chemical Company, Limited Organic sulfur compounds and use thereof as arthropodicides
JP2009001551A (ja) 2007-05-18 2009-01-08 Sumitomo Chemical Co Ltd 有機硫黄化合物及びその有害節足動物防除用途
TW200904329A (en) 2007-05-18 2009-02-01 Sumitomo Chemical Co Organic sulfur compound and its use for controlling harmful arthropod
JP5298631B2 (ja) 2007-05-18 2013-09-25 住友化学株式会社 有機硫黄化合物及びその有害節足動物防除用途
US8153846B2 (en) * 2007-12-03 2012-04-10 E.I. Du Pont De Nemours And Company Sulfur containing fluoroalkyl amines and isocyanates
EP2070941A1 (en) 2007-12-14 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Stereoselective synthesis of selective estrogen receptor down-regulators
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
CN104387435B (zh) * 2014-12-10 2017-05-10 天津孚音生物科技发展有限公司 一种化合物及其制备方法与应用
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
DE3925507A1 (de) * 1989-07-28 1991-01-31 Schering Ag 14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
DE19622457A1 (de) * 1996-05-24 1997-11-27 Schering Ag 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
US5866560A (en) * 1996-08-20 1999-02-02 Schering Ag 7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents
DE19635525A1 (de) 1996-08-20 1998-02-26 Schering Ag 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln

Also Published As

Publication number Publication date
WO1999042109A1 (de) 1999-08-26
AR017982A1 (es) 2001-10-24
IL137491A0 (en) 2001-07-24
CA2321427A1 (en) 1999-08-26
AU2834799A (en) 1999-09-06
PE20000261A1 (es) 2000-05-22
JP2002503695A (ja) 2002-02-05
ZA991370B (en) 1999-11-24
DE19807791A1 (de) 1999-08-26
EP1054676A1 (de) 2000-11-29
US6677324B1 (en) 2004-01-13

Similar Documents

Publication Publication Date Title
BR9908094A (pt) Preparado combinado de estrogênio e antiestrogênio
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
AR011480A1 (es) ACIL-ANILIDAS SUSTITUIDAS CON RADICALES (HETERO) CICLICOS, NO ESTEROIDALES, CON ACTIVIDAD GESTÁGENA Y ANDRoGENA MIXTA.
BR9911682A (pt) Metano sulfonato de paroxetina
BRPI0517752A (pt) processo para a preparação de drospirenona
BR0109983A (pt) Estratrienos substituìdos por 8.beta-hidrocarbila como estrogênios seletivamente eficientes
DK0771217T3 (da) Faste lægemiddelformer, som indeholder clathrater af det steroide könshormon ethinylestadiol
BR9811249A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
DK1315502T3 (da) Fremgangsmåde til behandling af erektil dysfunktion og til forøgelse af mænds libido
WO2001068074A3 (en) Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
BR9710198A (pt) Contraceptivo oral constituìdo por combinação farmacêutica de estrogênio-androgênio-progestina.
DK1353700T3 (da) Præparater af östrogencyclodextrinkomplekser
ES2118677T1 (es) Una composicion que comprende un agente activo disuelto en un vehiculo vitrificante y un procedimiento para su preparacion.
NO20062945L (no) Forlenget anvendelseskombinasjon omfattende ostrogener og progestiner
DK0868188T3 (da) Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen
CL2011000017A1 (es) Uso de una composicion farmaceutica que comprende i) 0,5 a 3 mg de un estrogeno seleccionado de estradiol libre, estradiol esterificado y estrogenos conjugados de equinos, ii) 1,5 a 3,75 de acetato de nomegestrol, y iii) excipientes farmaceuticos adecuados, para tratar deficiencias estrogenicas en mujeres postmenopausicas (divisional de solicitud 1997-02114).
ECSP084358A (es) NUEVAS FORMAS SÓLIDAS DE LA MESOPROGESTINA 11ß-[4E-(HIDROXIIMINOMETIL)-FENIL]- 17ALFA-METOXIMETIL-17ß-METOXI-ESTRA-4,9-DIEN-3-ONA
FI954579A0 (fi) Uusia pednisolonijohdannaisia
PT1272481E (pt) 4-trifluorometil-2h-benzopiranos antiestrogenicos com accao estrogenica selectiva
BR9913457A (pt) Neuroproteção
BR9809571A (pt) Composição medicinal e processo para produzì-la
BR0010709A (pt) Gonadotrofinas
Okulicz Effect of the antiprogestin RU-486 on progesterone inhibition of occupied nuclear estrogen receptor in the uterus
ES2148493T3 (es) Nuevos compuestos con efecto analgesico y anestesico local.
BR9806893A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 a 038 g/ml, compreendendo sulfato de terbutalina, processo para preparação da formulação e uso da mesma

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTA A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.